Abstract
Underestimating antimicrobial use based on days of therapy (DOT) is recognized for certain antimicrobial agents. We investigated the difference between DOT and therapeutic drug monitoring (TDM)-based exposure days in estimating vancomycin use and demonstrated that DOT may underestimate vancomycin exposure by ∼10%.
| Original language | English |
|---|---|
| Pages (from-to) | 375-379 |
| Number of pages | 5 |
| Journal | Infection Control and Hospital Epidemiology |
| Volume | 40 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 01-03-2019 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Epidemiology
- Microbiology (medical)
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Methods of estimating vancomycin use in an inpatient setting: Days of therapy versus therapeutic drug monitoring-based exposure days'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver